KR830002765B1 - Method for preparing medicinal extract from seeds of Cardus marianus - Google Patents
Method for preparing medicinal extract from seeds of Cardus marianus Download PDFInfo
- Publication number
- KR830002765B1 KR830002765B1 KR1019820002630A KR820002630A KR830002765B1 KR 830002765 B1 KR830002765 B1 KR 830002765B1 KR 1019820002630 A KR1019820002630 A KR 1019820002630A KR 820002630 A KR820002630 A KR 820002630A KR 830002765 B1 KR830002765 B1 KR 830002765B1
- Authority
- KR
- South Korea
- Prior art keywords
- seeds
- solvent
- extract
- marianus
- extraction
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims description 33
- 238000000034 method Methods 0.000 title claims description 31
- 239000002904 solvent Substances 0.000 claims description 44
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 33
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 24
- 238000000605 extraction Methods 0.000 claims description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 10
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 8
- 150000002148 esters Chemical class 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- 238000007906 compression Methods 0.000 claims description 7
- 230000006835 compression Effects 0.000 claims description 7
- 230000018044 dehydration Effects 0.000 claims description 7
- 238000006297 dehydration reaction Methods 0.000 claims description 7
- 150000001298 alcohols Chemical class 0.000 claims description 6
- 229930195734 saturated hydrocarbon Natural products 0.000 claims description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 239000012046 mixed solvent Substances 0.000 claims description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 description 21
- 239000002244 precipitate Substances 0.000 description 20
- 239000000706 filtrate Substances 0.000 description 19
- 239000000126 substance Substances 0.000 description 11
- 239000000843 powder Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- 238000005238 degreasing Methods 0.000 description 8
- 235000019441 ethanol Nutrition 0.000 description 8
- 239000000654 additive Substances 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 208000019423 liver disease Diseases 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000001814 pectin Substances 0.000 description 3
- 229920001277 pectin Polymers 0.000 description 3
- 235000010987 pectin Nutrition 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000002861 polymer material Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000015163 Biliary Tract disease Diseases 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 235000007542 Cichorium intybus Nutrition 0.000 description 1
- FDQAOULAVFHKBX-UHFFFAOYSA-N Isosilybin A Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC(=CC=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 FDQAOULAVFHKBX-UHFFFAOYSA-N 0.000 description 1
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 1
- -1 Phosphorus ethers Chemical class 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- VLGROHBNWZUINI-UHFFFAOYSA-N Silybin Natural products COc1cc(ccc1O)C2OC3C=C(C=CC3OC2CO)C4Oc5cc(O)cc(O)c5C(=O)C4O VLGROHBNWZUINI-UHFFFAOYSA-N 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 238000000975 co-precipitation Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 238000000710 polymer precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 1
- 229940043175 silybin Drugs 0.000 description 1
- 235000014899 silybin Nutrition 0.000 description 1
- CYGIJEJDYJOUAN-JSGXPVSSSA-N silydianin Chemical compound C1=C(O)C(OC)=CC([C@H]2[C@H]3C=C([C@@H]4[C@@](C3=O)(O)OC[C@@H]42)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 CYGIJEJDYJOUAN-JSGXPVSSSA-N 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
내용 없음.No content.
Description
본 발명은 카르두스 마리아누스(Cardus Marianus)의 종자로부터 간장질환의 치료에 사용될 수 있는 약용 엑기스를 제조하는 방법에 관한 것이다.The present invention relates to a method for preparing a medicinal extract that can be used for the treatment of liver disease from the seed of Cardus Marianus.
카르두스 마리아누스는 국화과에 속하는 식물로써 남구라파, 남미등지에서 야생 또는 재배되고 있다.Cardus Marianus is a plant belonging to the Asteraceae family and is wild or cultivated in southern Europe and South America.
카르두스 마리아누스의 종자(이하 종자라 칭한다)는 예로부터 그 자체 또는 민들레, 치코리등의 식물과 같이 차(茶)로 하여 각종 간질환 및 담도 질환에 사용되어 왔다.The seeds of Cardus marianus (hereinafter referred to as seeds) have been used for various liver diseases and biliary tract diseases as tea by themselves or like plants such as dandelion and chicory.
19세기 초반 독일인 의사 라데마커는 이 종자의 임상효과를 체기적으로 연구한 바 있었으며, 그 결과 이 종자는 간장질환에 탁월한 효과가 있음을 알게 되었다.In the early 19th century, German physician Rademarker studied the clinical effects of these seeds physically, and as a result, the seeds were found to have an excellent effect on liver disease.
최근에 와서 바그너, 헨젤은 각각 독립적으로 종자로부터 유효성분을 추출 분리하고 그 화학구조를 결정하는데 성공하였다. 또한 독일의 중앙 암연구소에서는 순수 단리된 물질을 사용하여 분자 생물학적 실험을 행하였으며, 그 결과 이물질이 파괴된 간장세포의 재생을 촉진하고 있음을 밝혀냈다.In recent years, Wagner and Hansel have succeeded in independently extracting and separating active ingredients from seeds and determining their chemical structure. In addition, the German Central Cancer Institute conducted molecular biological experiments using purely isolated materials, and found that the foreign material promotes the regeneration of destroyed hepatic cells.
이로써 이 식물의 의약학적 가치는 입증되었다.This proved the plant's medicinal value.
이 종자로부터 현대 약학적 제제를 만드는 방법은 여러가지가 알려졌고, 유효 성분들의 성상이 알려짐으로써 이를 정량하는 방법이 연구 개발되어 그 결과로 가능한 고농도의 유효성분을 함유하는 제제의 제조방법도 개발되어 있다.There are many known methods for making modern pharmaceutical formulations from these seeds, and methods for quantifying the active ingredients are known and developed. As a result, methods for preparing formulations containing high concentrations of active ingredients have been developed.
종자의 유효성분은 플라본오이드 물질균에 속하는 것으로서, 실리빈, 실리디아닌, 실리크리스린으로 되어있다.The active ingredient of the seed belongs to the flavonoid material bacterium, and consists of silybin, silidianine, and silicryrin.
종래의 방법은 특허공고 제76-461호에서 공개된 바와같이 실리붐 마리아눔 종자를 유종자용 스크류프레스에서 고압 압착탈지시킨 다음, 잔사를 초산에틸로 추출하고, 용제를 증발시켜 유성의 건성 잔류물를 얻고 이를 메탄올/물/석유에테르 3성분 계의 하층상에 향류로 다만 분배시키고 원심분리한 후 고체성분을 제거한 청징액을 전공 농축시켜 시리마린을 얻는 방법으로써 다단계의 매우 번잡한 방법이나, 이에 비하여 본 발명은 추출단계가 적고 또한 추출이 매우 용이한 것을 특징으로 하고 있으므로 현저한 기술의 전보성이 있고 원가면에서도 유리한 방법인 것이다.The conventional method is to decompress the silyboom marianum seeds in a seed press screw press as disclosed in Patent Publication No. 76-461, extract the residue with ethyl acetate, and evaporate the solvent to remove the oily dry residue. This is obtained by only distributing the countercurrent in countercurrent on the lower layer of the methanol / water / petroleum ether system, centrifuging, and concentrating the clarified liquid from which the solid component is removed to obtain sirimarin. The present invention is characterized by low extraction steps and very easy extraction, which is a method of remarkable technology and is advantageous in terms of cost.
즉, 본 발명의 추출공정은 종자의 탈지(脫脂), 탈수(脫水), 용매추출의 3단계로 되어 있는데, 이를 상세히 설명하면 다음과 같다.That is, the extraction process of the present invention consists of three steps of degreasing (脫脂), dehydration (脫水), solvent extraction of the seed, which will be described in detail as follows.
우선, 종자를 속스테트부 압착추출기(주 : 속스테트장치가 달린 압착추출기를 의미함)에 넣고 종자의 껍질이 파괴되도록 2-3회 압착한 후 여기에 비극성용패를 가하고 교반한 후 압착하여 용매와 그 용존물을 속스테트의 증발부에 보낸다.First, put the seeds in the Soksteek part compression extractor (Note: means a compression extractor with Sokstete device) and squeezed 2-3 times so that the shell of the seed is destroyed, add a non-polar plaque to it, stir and compress The solvent and its dissolved solution are sent to the evaporation section of Soxteut.
속스테트의 증발부로부터 용매를 증발시켜 압착한 종자에 보낸다. 이렇게 하여 압착한 종자에 일정한 용매량이 되면 압착피스톤에 부착된 교반기로 종자분을 교반한 후 다시 압착하여 용매와 용존물은 증발부로 보낸다. 이렇게 반복하여 완전 탈지시킨다. 이때 사용한 용매는 비극성인 탄소수 5-8의 직쇄 또는 분기상 포화탄화수소이다.The solvent is evaporated from the evaporation section of Soxtete and sent to the pressed seeds. In this way, when the amount of solvent in the pressed seeds is stirred, the seed powder is stirred with a stirrer attached to the pressed piston, and then pressed again, and the solvent and the dissolved substance are sent to the evaporator. Repeat this to complete degreasing. The solvent used at this time is a non-polar straight-chain or branched saturated hydrocarbon of 5-8 carbon atoms.
종자에 대한 탈지용매의 양은 2-7배의 범위가 좋으며, 용매의 종류, 양 및 종자의 량에 따라 탈지시간은 20-180분이면 된다. 탈지용매로서 포화탄화수소를 사용하여 얻는 장점은 유효성분의 손실을 적게 하는데 있다. 용매 없이 종자를 압착하여도 상당한 량의 불필요한 물질을 제거할 수 있으나 압착되어 나오는 지질중에 극성물질이 혼재하여 있으므로 극성인 유효성분이 지질에 용해되어 유효성분의 손실이 온다.The amount of the degreasing solvent for the seed is preferably in the range of 2-7 times, and the degreasing time may be 20-180 minutes depending on the type of solvent, the amount and the amount of the seed. The advantage of using saturated hydrocarbon as a degreasing solvent is to reduce the loss of active ingredients. Although compressing the seed without the solvent can remove a considerable amount of unnecessary substances, polar substances are mixed in the compressed lipids, so that the polar active ingredients are dissolved in the lipids, resulting in loss of the active ingredients.
그러나 본 발명의 포화탄화수소 용매는 지질만 선택하여 용해시킴으로써 용액 자체가 비극성이므로 비교적 극성이 높은 유효성분은 이 용액에 용출되지 않는다.However, the saturated hydrocarbon solvent of the present invention selects and dissolves only lipids so that the solution itself is nonpolar, so that an active ingredient having a relatively high polarity is not eluted into the solution.
위에 기술한 탈지공정은 용매의 소비가 적고 탈지시간이 단축되는 장점이 있으므로 본 발명의 첫째 요소가 되는 것이다.The degreasing process described above is the first element of the present invention because it has the advantage of low solvent consumption and short degreasing time.
다음으로 이와같이 탈지된 종자분은 수분을 함유하고 있는데, 이들 수분은 화학적으로 비교적 자유스런 상태로 존재하기도 하며, 고분자나 극성물질과 분자결합을 하고 있기도 하다.Next, the seed powder thus degreased contains water, which may exist in a relatively free state chemically, and may have molecular bonds with polymers or polar substances.
예컨대, 펙틴질은 물을 함유하게 되면 물분자와 수소결합 등 화학결합을 함으로써 분자 자체가 평배되고 이 상태의 펙틴질은 알콜류 또는 기타 수소결합의 능력을 갖는 용매와 접촉하게 되면 상당한 량이 이 용매에 용존되거나 또는 유화되어 나온다. 말하자면, 종자분의 수분을 제거하지 않은 채 수소결합의 능력을 갖고있는 용매로 종자분을 추출하면 상당량의 고분자물질이 유효성분과 같이 추출된다. 그 반대로 건조상태의 펙틴질의 이들 용매에 대한 용해도는 훨씬 낮아진다.For example, when pectin contains water, chemical molecules such as hydrogen bonds with water molecules make the molecules themselves flattened. Pectin in this state is dissolved in a significant amount in contact with alcohols or other solvents capable of hydrogen bonding. Or emulsified. In other words, when the seed is extracted with a solvent having the ability of hydrogen bonding without removing the moisture of the seed, a considerable amount of the polymer is extracted together with the active ingredient. In contrast, the solubility of dry pectin in these solvents is much lower.
이와같은 성질을 갖는 고분자물질에는 펙틴질의 단백질, 펩리트, 탄수화물등이 속한다.Pectin-like proteins, peptides, carbohydrates, and the like belong to polymer materials having such properties.
결론적으로, 이와같은 고분자물질의 유기용매에 대한 용출량을 줄이기 위하여는 종자부의 탈수조작이 선행되어야 한다. 탈수조작은 20-40℃의 온도에서 감압하에 하는 것이 좋다.In conclusion, in order to reduce the elution amount of the polymer material into the organic solvent, the dehydration operation of the seed part should be preceded. Dehydration operation is preferably carried out under reduced pressure at a temperature of 20-40 ℃.
이와같은 탈수방법은 용매추출과정에서 고분자물질의 용출을 억제함으로써 일차 추출물중 유효성분의 농도를 올릴 수 있으며, 뛰따르는 고농도 추출물의 제조에 편의성을 줌으로써, 이 탈수공정은 본 발명의 둘째요소가 되는 갓이다.Such a dehydration method can raise the concentration of the active ingredient in the primary extract by inhibiting the elution of the polymer material in the solvent extraction process, and by providing convenience to the preparation of the high concentration extract to run, this dehydration process is the second element of the present invention It's fresh.
마지막으로 탈지 및 탈수된 종자분으로부터 유효성분을 추출하기 위하여 유기용매를 사용하였다.Finally, an organic solvent was used to extract the active ingredient from the degreased and dehydrated seed meal.
유기용매는 알콜류, 케론류, 또는 에스레르류들이다.Organic solvents are alcohols, kerons, or eslers.
상기 알콜류는 일반식(I)의 R1OH (식중 R1은 C1-C4의 알킬기를 나타낸다)이고, 케론류는 일반식(Ⅱ)의 R2CO-R3(식중 R2의 R3는 각각Cl-C3의 알킬기를 표시한다)이며, 에스테트류는 일반식(Ⅲ)의 R4COOR(식중 R4와 R5는 각각 Cl-C3의 알킬기를 표시한다)이다.The alcohols are R 1 OH of Formula (I) (wherein R 1 represents an alkyl group of C 1 -C 4 ), and kerons are R 2 CO—R 3 of Formula (II) (wherein R 2 3 each represents an alkyl group of C 1 -C 3 , and the esters are R 4 COOR of Formula (III), wherein R 4 and R 5 each represent an alkyl group of C 1 -C 3 .
일정량의 탈지 및 탈수된 종자분을 이들 용매로 전기한 속스테르부 압착추출기로 추출한 다음 추출용액을 일정량까지 농축한다. 농축된 추출용액을 5-25℃의 온도범위에서 방치하고, 생성된 침진을 제거한다. 침전중에 유효성분이 함유되어 나오지 않는 한도내에서 최소량의 추출용액이 남을 때까지 위의 침전조작을 반복한다. 이와같이 하면 용매의 성질에 따라 30-45%의 유효성분이 함유된 건조추출물을 제조할 수 있었다.A certain amount of degreased and dehydrated seed powder is extracted with a Soxter part compression extractor, which is described above with these solvents, and then the extraction solution is concentrated to a certain amount. The concentrated extract solution is left to stand at a temperature range of 5-25 ° C. and the resulting precipitate is removed. Repeat the above precipitation procedure until the minimum amount of extraction solution remains within the limit that no active ingredient is contained during the precipitation. In this way, a dry extract containing 30-45% of the active ingredient was prepared depending on the nature of the solvent.
이와같이 제3공정의 단용매(單溶媒) 처리공정으로 약학적으로 이용될 수 있는 고농도의 추출물을 제조하는 단계는 본 발명의 셋째 요소가 되는 것이다.As such, the step of preparing a high concentration of extract that can be used pharmaceutically as the monosolic treatment of the third step is to be the third element of the present invention.
상기와 같은 단용매 추출에 있어서, 추출온도를 상승시키면 추출속도가 빨라지는 반면, 추출원액이 현락될 정도로 불순물이 많이 추출되는 단점이 있다.In the extraction of the single solvent as described above, while increasing the extraction temperature, the extraction speed is increased, while there is a disadvantage that a lot of impurities are extracted so that the extraction stock solution is suspended.
높은 온도에서는 유효성분의 화학적 변화가 일어날 우려도 있다. 추출용매의 량은 용매의 종류, 추출조건에 따라 사용종가의 량에 대하여 3-10배이다. 속스테트부 압착추출기를 사용하기 때문에 실제로 과량의 용매는 필요가 없는 것이 또한 본 발명의 장점이다.At high temperatures, chemical changes in the active ingredient may occur. The amount of the extraction solvent is 3-10 times the amount of the used value according to the type of solvent and the extraction conditions. It is also an advantage of the present invention that no excess solvent is actually necessary because of the use of a fast steep extractor.
고농도의 총 폴라본오이드를 함유하는 추출물을 만드는데는 종래에 여러가지 방법이 이용될 수 있었다.Various methods have been conventionally used to make extracts containing high concentrations of total polarvonoids.
즉, 폴리아미드, 세파덱스, 셀루로스등을 사용한 크로마로그라피법, 무기이온 또는 고분자 침전제를 사용한 유효성분의 공침법등이 있다. 그러나 크로마토그라피법등 종래의 방법들은 대량 생산에는 비경제적이며, 공치법을 사용하면 유효성분의 손실, 외부물질이 혼입될 우려등의 단점을 값고 있다.That is, the chromatographic method using polyamide, Sephadex, cellulose, etc., the coprecipitation method of the active ingredient using an inorganic ion or a polymer precipitation agent, etc. are mentioned. However, conventional methods, such as chromatographic methods, are uneconomical for mass production, and use of nominal methods has the disadvantages of loss of active ingredients and fear of mixing of foreign substances.
따라서 본 발명에서는 혼합용매법으로 총 폴라본오이드의 순도를 높이는 방법을 개발하였다. 즉, 이미 상당한 량의 폴라본 오이드양을 함유하고 있는 단용매 추출액 일정량에다 극성이 낮은 용매를 혼합함으로써 추출액중의 고분자물질 및 극성이 높은 물질들을 제거하는 방법이다.Therefore, the present invention has been developed a method of increasing the total purity of the polar bonoids by a mixed solvent method. That is, a method of removing the high-molecular substances and the high-polar substances in the extract by mixing a low polarity solvent with a predetermined amount of a single solvent extract that already contains a considerable amount of the amount of the polar bonide.
이때 사용한 첨가용매는 위에 언급한 일반식(Ⅲ)의 R4COOR5인 에스테르류 또는 일반식(Ⅳ)의 R6-O-R7(식중 R6와 R7은 Cl-C4의 알킬기이다)인 에테르류이며, 그밖에 테트라하이드로 후란과 디옥산도 첨가용매로 사용되며, 또한 할로겐화 알킬류, 예컨대 크로로포름, 사염화탄소도 첨가용매로서 사용된다.The addition solvent used at this time is the above-mentioned ester of R 4 COOR 5 of general formula (III) or R 6 -OR 7 of general formula (IV), wherein R 6 and R 7 are C 1 -C 4 alkyl groups. Phosphorus ethers, tetrahydrofuran and dioxane are also used as addition solvents, and halogenated alkyls such as chloroform and carbon tetrachloride are also used as addition solvents.
그러나, 이외의 할로겐화 알킬류의 용매의 급격한 극정의 저하를 유발함으로써 첨가용매로서 사용하기 어렵다. 순수한 탄화수소 용매를 첨가용매로 사용할 경우에도 혼합용액의 급격한 극정 저하때문에 유효성분의 최적농도를 조절하기가 대단히 어렵다. 그러므로 첨가용매로서 가장 적합한 물질군은 상기 일반식(Ⅲ)의 에스테르류와 상기 일반식(Ⅳ)의 에테르류, 테트라하이드로후란, 디옥산, 그리고 크로로포름과 사염화탄소이다.However, it is difficult to use it as an additive solvent by causing the abrupt fall of the solvent of other halogenated alkyls. Even when a pure hydrocarbon solvent is used as an additive solvent, it is very difficult to control the optimum concentration of the active ingredient due to the drastic extreme decrease of the mixed solution. Therefore, the most suitable substance group as an additive solvent is the ester of the general formula (III) and the ethers of the general formula (IV), tetrahydrofuran, dioxane, chloroform and carbon tetrachloride.
이들은 그들 자체가 유효성분에 대하여 용해도를 갖고 있으면서 용액중에 함유되어 있는 더욱 극성이 강한 분자들, 즉, 용해도가 적은 고분자물질을 침전시키는 역할을 한다.They serve to precipitate more polar molecules, i.e., less soluble polymers, which are themselves in solution while having solubility in the active ingredient.
이와같이 용매의 극성을 조절함으로써 유효성분의 순도를 높이는 조작은 본 발명의 중요한 요소이다.Thus, the operation of increasing the purity of the active ingredient by adjusting the polarity of the solvent is an important element of the present invention.
종자 1kg으로부터 얻은 단용매 추출액 일정량에 대한 첨가용매의 량은 다음 표 1과 같이 나타났다.The amount of the added solvent with respect to a predetermined amount of the monosolvent extract obtained from 1 kg of seeds was shown in Table 1 below.
[표 1]TABLE 1
단용매 농축액의 량에대한 첨가용매의 량Amount of Solvent Added to Monosol Concentrate
(단위 : ml)(Unit: ml)
유효성분에 대하여 용해도가 클 일반식(Ⅲ)의 에스테르류를 사용하는 경우에는 단용매 추출액의 양을 최소한으로 유지하는 것이 유리하다.When esters of general formula (III) having high solubility with respect to the active ingredient are used, it is advantageous to keep the amount of the monosolvent extract to a minimum.
예컨대, 1㎏의 종자로부터 언은 알콜류의 추출액의 량을 200-300㎖로 농축하고 여기에 에스테르류를 1-2배의 범위로 가하면 유효성분의 순도를 쉽게 올릴 수가 있다.For example, if the amount of extract of alcohols frozen from 1 kg of seeds is concentrated to 200-300 ml and the esters are added in a range of 1-2 times, the purity of the active ingredient can be easily increased.
첨가용매를 가할 때 최적온도는 실온의 범위인 15-35℃가 좋고 첨가혼합후 방치온도는 5-25℃이다. 방치 시간은 용매의 종류에 따라 3-l2시간이다.When the addition solvent is added, the optimum temperature is 15-35 ℃, which is a range of room temperature, and the standing temperature after mixing is 5-25 ℃. The standing time is 3-l 2 hours depending on the type of solvent.
이와같이 혼합용매 방법을 사용하여 총플라본오이드의 함량 70-80% 범위의 건조추출물을 제조할 수 있으며, 다음의 몇가지 실시예로서 본 발명의 공정을 더욱 구체적으로 설명한다.Thus, using the mixed solvent method can be prepared a dry extract in the range of 70-80% of the total flavonoid content, the process of the present invention will be described in more detail in the following examples.
[실시예 1]Example 1
제1공정(탈지 및 건조공정)First process (degreasing and drying process)
1㎏의 종자를 속스테르부 압착추출기(이하 추출기라 한다)에 넣고 종자가 파괴될 정도로 2-5회 압착한다.1 kg of seeds are placed in a Sokster part extractor (hereinafter referred to as an extractor) and pressed 2-5 times so that the seeds are destroyed.
다음 N-헥산 1.5lℓ를 분쇄된 종자에 가하고 잘 교반한후 압착하여 용매 및 그의 용해물질을 압착 제거한다.Next, 1.5 l of N-hexane is added to the pulverized seed, stirred well, and pressed to remove the solvent and its dissolved material.
1.5ℓ의 용매를 사용하여 다시 같은 조작을 한다.The same operation is performed again using 1.5 L of solvent.
속스테르 시스템을 가동하여 2시간 동안 계속 압착 추출한다.Run the Soxter system and continue to squeeze for 2 hours.
용매가 완전히 제거된 종자분은 감압건조기에 넣고 실온에서 12시간 건조하여 건조종자분 668g을 얻었다. (수율 66.8%)The seed powder from which the solvent was completely removed was put in a vacuum dryer and dried at room temperature for 12 hours to obtain 668 g of dry seed powder. (Yield 66.8%)
제2공. (추출공정)Second ball. Extraction process
종자 1㎏을 제1공정으로 처리하여 종자분 700g을 얻는다. (수율 77%)1 kg of seeds is treated in a first step to obtain 700 g of seed powder. (Yield 77%)
이 종자분을 추출기에 넣고 2ℓ의 메탄올로서 3시간 동안 25℃에서 압착 추출한다. 마지막 압착후 얻어지는 약 2ℓ의 메탄올 추출용액은 전체량이 500㎖되게 농축한 후 5℃에서 12시간 방치한다.This seed is placed in an extractor and press-extracted at 25 ° C. for 3 hours with 2 liters of methanol. The methanol extract solution of about 2 L obtained after the final compression was concentrated to 500 ml and left at 5 ° C. for 12 hours.
생성된 침전은 여과하여 제거하고 여액은 다시 농축하여 300㎖가 되게 하고 5℃에서 12시간 방치한다.The resulting precipitate is filtered off and the filtrate is concentrated again to 300 ml and left at 5 ° C. for 12 hours.
이때 성립된 침전은 제거하고 여액은 농축 건조추출물 49.4g을 얻었다.At this time, the precipitate was removed and the filtrate was obtained 49.4g of concentrated dry extract.
제3공정 (정제공정)3rd process (purification process)
제2공정으로 제조한 메틸알콜 농축액 300㎖를 2ℓ비이커에 넣고 교반하면서 500㎖의 에틸아세테이르를 천천히 가한다음 10분간 교반한후 1시간 방치한다.300 ml of the methyl alcohol concentrate prepared in the second step was added to a 2 L beaker, and 500 ml of ethyl acetate was slowly added while stirring. After stirring for 10 minutes, the mixture was left for 1 hour.
이때 생성된 침전은 여과하고 여과지상의 고형물은 100㎖의 에틸아세테이트로 세척한다.The precipitate produced is filtered and the solid on the filter paper is washed with 100 ml of ethyl acetate.
합친 여액은 증발 건조하여 건조추출물 32' 을 언었다.The combined filtrates were evaporated to dryness to freeze dry extract 32 '.
[실시예 2]Example 2
종자 1㎏을 실시예 1의 제1공정과 같은 방법으로 종자분 600g을 얻는다. (수율 60%)1 kg of seed is obtained in the same manner as in the first step of Example 1 to 600 g of seed powder. (Yield 60%)
제2공정2nd process
종자분을 추출기에 넣고 에틸알콜 2ℓ로 25℃에서 3시간 압착 추출한다. 에틸알콜추출액 약 2ℓ를 500㎖가 되게 농축하고 5℃에서 12시간 방치한다. 이때 생성된 침전은 여과하여 제거하고 여액은 다시 300㎖가 되게 농축시킨 다음 5℃에서 12시간 방치한다. 생성된 침전은 여과하여 제거하고 여액은 증발 건조하여 건조추출물 47.lg을 얻었다.Seed powder was added to an extractor and extracted by compression of 2 liters of ethyl alcohol at 25 ° C. for 3 hours. About 2 L of ethyl alcohol extract was concentrated to 500 ml and left at 5 ° C for 12 hours. At this time, the resulting precipitate is removed by filtration and the filtrate is concentrated to 300ml again and left for 12 hours at 5 ℃. The resulting precipitate was filtered off and the filtrate was evaporated to dryness to obtain 47.lg of dry extract.
제3공정3rd process
제2공정에 의하여 에틸알콜 농축액 300㎖를 만들어 2ℓ의 비이커에 넣고 교반하여 준다. 여기에 에틸아세테이르 500㎖를 가해준 다음 10분간 교반한다. 3시간 방치후 생성된 침전은 여과한다. 여과지상의 고형물은 에틸아세테이르 100㎖로 세척한다. 합친 여액을 증발 건조하여 20g의 건조추출물을 얻었다.300 ml of ethyl alcohol concentrate was prepared by the second step and placed in a 2 L beaker and stirred. 500 ml of ethyl acetate was added thereto, followed by stirring for 10 minutes. After standing for 3 hours, the resulting precipitate is filtered. The solid on the filter paper is washed with 100 ml of ethyl acetate. The combined filtrates were evaporated to dryness to obtain 20 g of dry extract.
[실시예 3]Example 3
실시예 2의 제2공정으로 만든 에틸알클 농축액 500㎖를 2ℓ비이커에 넣고 교반하면서 에틸에텔 178㎖를 소량씩 가한다음 5℃에서 12시간 방치한다. 생성된 침전은 여과하여 제거한후 여액에 80㎖의 에틸에텔을 추가한 후 다시 5℃에서 방치한다.500 ml of the ethyl alkal concentrate prepared in the second step of Example 2 was added to a 2 L beaker, and 178 ml of ethyl ether was added little by little while stirring, followed by standing at 5 ° C. for 12 hours. The precipitate formed is filtered off, and 80 ml of ethyl ether is added to the filtrate, and the mixture is left at 5 ° C.
생성된 침전은 여과하여 제거하고 여액은 증발건조하여 얻어진 건조 추출물의 무게는 27.4g이었다.The resulting precipitate was filtered off and the filtrate was evaporated to dryness to weigh 27.4 g of the dry extract.
[실시예 4]Example 4
실시예 2의 제2공정으로 제조한 에틸알콜 농축액 500㎖를 2ℓ비이커에 넣고 교반하면서 에틸에텔 200㎖를 서서히 가한다. 10분간 교반을 계속한 후 혼합용액은 5℃에서 12시간 방치한다. 생성된 침전은 여과하여 제거하고 여액에는 에틸에텔 100㎖를 추가하여 혼합하고 다시 5℃에서 12시간 방치한다. 생성된 침전은 여과하여 제거하고 여액은 증발 건조하여 건조추출물 26g을 얻었다.500 ml of ethyl alcohol concentrate prepared in the second step of Example 2 was added to a 2 L beaker and 200 ml of ethyl ether was slowly added while stirring. After the stirring was continued for 10 minutes, the mixed solution was left at 5 ° C for 12 hours. The resulting precipitate is removed by filtration, 100 ml of ethyl ether is added to the filtrate, mixed and left to stand again at 5 ° C for 12 hours. The resulting precipitate was removed by filtration and the filtrate was evaporated to dryness to obtain a dry extract 26g.
[실시예 5]Example 5
종자 1㎏을 사용하여 실시예 1의 제1공정으로 종자분 692g을 제조한다(수율 69.2%)Using 1 kg of seeds, 692 g of seed was prepared in the first step of Example 1 (yield 69.2%).
제2공정2nd process
종자분을 추출기에 넣고 에틸아세테이트 2ℓ로 5시간 추출한다. 속스테르 후라스크 내의 약 2ℓ의 에틸아세테이르 용액을 500m가 되게 농축한 다음 5℃에서 12시간 방치한다. 생성된 침전은 여과하여 제거하고 여액은 다시 농축하여 180㎖가 되게 하여 다시 5℃에서 12시간 방치한다. 생성된 침전은 여과하여 제거하고 여액은 증발 건조하여 건조추출물 30.3g을 얻었다.Seed powder is added to the extractor and extracted with 2 liters of ethyl acetate for 5 hours. The solution of about 2 L of ethyl acetate in Soxter Furask was concentrated to 500 m and then left at 5 ° C. for 12 hours. The resulting precipitate is filtered off and the filtrate is concentrated again to 180 ml and left at 5 ° C. for 12 hours. The resulting precipitate was filtered off and the filtrate was evaporated to dryness to obtain 30.3 g of a dry extract.
제3공정3rd process
제2공정에 의하여 얻은 에틸아세테이르 농축액 500㎖를 2ℓ비이커에 넣고 교반해 주면서 에틸에텔 210㎖를 서서히 가한다. 10분간 더 교반한후 혼합용액을 5℃에서 12시간 방치한다. 생성된 침전은 여과하여 제거하고 여액에는 다시 에틸에텔 67㎖를 가하고 혼합한다. 이 혼합액을 다시 5℃에서 12시간 방치한다. 생성된 침전은 여과하여 제거하고 여액은 증발 건조하여 건조추출을 24.7g을 얻었다.500 ml of ethyl acetate concentrate obtained in the second step was added to a 2 L beaker and 210 ml of ethyl ether was slowly added while stirring. After further stirring for 10 minutes, the mixed solution is left at 5 ℃ for 12 hours. The precipitate formed is filtered off and 67 ml of ethyl ether is added to the filtrate and mixed. This mixed solution is left to stand again at 5 ° C for 12 hours. The produced precipitate was removed by filtration and the filtrate was evaporated to dryness to give a dry extract 24.7g.
[실시예 6]Example 6
1㎏의 종자로부터 실시예 1의 제1공정에 의하여 종자분 678g을 얻는다. (수율 67.8%)678 g of seed powder are obtained by the first step of Example 1 from 1 kg of seeds. (Yield 67.8%)
제2공정2nd process
이를 추출기에 넣고 2ℓ의 아세톤으로 3시간 추출하였다. 약 2ℓ의 아세톤 추출액을 500㎖가 되게 농축한후 5℃에서 12시간 방치한다. 생성된 침전은 여과하여 버리고 여액은 다시 농축하여 200㎖가 되게 한후 다시 5℃에서 방치한다. 생성된 침전은 여과하여 제거하고 여액은 증발 건조하여 건조추출물 36.4을 얻었다.This was put into an extractor and extracted with 2 L of acetone for 3 hours. The acetone extract was concentrated to 500 ml and left at 5 ° C. for 12 hours. The resulting precipitate is filtered off and the filtrate is concentrated again to 200 ml and then left at 5 ° C. The produced precipitate was removed by filtration and the filtrate was evaporated to dryness to obtain a dry extract 36.4.
제3공정3rd process
제2공정에 따라 만든 아세톤 농축액 500㎖에 에틸에텔 100㎖를 가하여 혼합한다. 이때 생성된 침전은 여과하여 제거하고 여액에는 다시 100㎖의 에틸에텔을 가하여 혼합한 후 5℃에서 12시간 방치한다. 생성된 침전은 여과하여 제거하고 여액에는 다시 50㎖의 에틸에텔을 추가하여 혼합하고 5℃에서 12시간 방치한다. 생성된 침전은 여과하여 제거하고 여액은 증발 건조하여 건조추출물 26.5g을 얻었다.100 ml of ethyl ether was added to 500 ml of the acetone concentrate prepared according to the second step and mixed. At this time, the produced precipitate is removed by filtration, and the filtrate is added again to 100 ml of ethyl ether, mixed and left to stand at 5 ° C. for 12 hours. The produced precipitate is removed by filtration, and the filtrate is further added by adding 50 ml of ethyl ether, mixed and left at 5 ° C. for 12 hours. The resulting precipitate was filtered off and the filtrate was evaporated to dryness to give 26.5 g of dry extract.
테르라하이드로후란, 디옥산, 클로로포름 및 사염화탄소를 첨가용매로 사용하여 실시예 1-6과 유사한 방법으로 건조추출물을 제조한 결과를 다음 표 2에 기술한다.The result of preparing a dry extract in the same manner as in Example 1-6 using terahydrofuran, dioxane, chloroform and carbon tetrachloride as an additive solvent is shown in Table 2 below.
[표 2]TABLE 2
첨가용매 사용시의 효과 대비표Comparison table of effects of using solvent
단위 : 첨가량 및 농축량 : mlUnit: amount and concentration: ml
건조물량 : gDrying quantity: g
순 도 : %Purity:%
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019820002630A KR830002765B1 (en) | 1982-06-14 | 1982-06-14 | Method for preparing medicinal extract from seeds of Cardus marianus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019820002630A KR830002765B1 (en) | 1982-06-14 | 1982-06-14 | Method for preparing medicinal extract from seeds of Cardus marianus |
Publications (1)
Publication Number | Publication Date |
---|---|
KR830002765B1 true KR830002765B1 (en) | 1983-12-14 |
Family
ID=19224903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019820002630A KR830002765B1 (en) | 1982-06-14 | 1982-06-14 | Method for preparing medicinal extract from seeds of Cardus marianus |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR830002765B1 (en) |
-
1982
- 1982-06-14 KR KR1019820002630A patent/KR830002765B1/en active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20090285911A1 (en) | Cynara scolymus extracts, the use thereof and formulations containing them | |
JPH01108952A (en) | Method for manufacturing spice extract | |
DD247567A7 (en) | METHOD FOR PRODUCING BIOLOGICALLY ACTIVE POLYSACCHARIIDE CONCENTRATES AND MEDICAMENTS CONTAINING THEM | |
CN105175266A (en) | Method for extracting chlorogenic acid and caffeic acid from coffee beans | |
FR2749303A1 (en) | PROCESS FOR EXTRACTING CATECHIC POLYPHENOLS FROM POTENTIALLY OBTAINED EXTRACTS AND USE THEREOF | |
EP0456023B1 (en) | Process for preparation of catechol complexes | |
US4537774A (en) | Hot-water extracts of neem bark | |
US4536496A (en) | Polysaccharides N9GI, their preparation and therapeutic compositions containing them | |
RU2399379C2 (en) | Salix extract, its application and compositions containing it | |
US20020009509A1 (en) | Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition | |
KR830002765B1 (en) | Method for preparing medicinal extract from seeds of Cardus marianus | |
RU2676271C1 (en) | Method of complex processing of brown algae | |
SU1220563A3 (en) | Method of producing agent possessing lithiolytic action | |
FR2693906A1 (en) | Crude extracts of blue-green algae, their preparation processes and their applications in cosmetology and dermatology. | |
CN114315566A (en) | Method for simultaneously preparing rosemary oil soluble and fat soluble antioxidant | |
JP2003235502A (en) | Extraction method of ganoderma lucidum extract | |
RU2104025C1 (en) | Method of ginseng dry extract preparing | |
RU2177793C1 (en) | Method to obtain antiphlogistic activity-bearing polysaccharide sum | |
KR100385311B1 (en) | Process for preparing ginkgo-tea and ginkgo-tea prepared thereby | |
US6858233B2 (en) | Simmondsin processing methods and products | |
RU2394587C1 (en) | Medication possessing hypocholesterolemic, hypolipidemic and cholagogic action | |
RU2402525C1 (en) | Method of obtaining rosmarinic acid | |
RU2232774C1 (en) | Method for preparing water-soluble polysaccharide | |
RU2043100C1 (en) | Method of lipid preparing from medicinal dirts | |
SU1187825A1 (en) | Method of obtaining flamine and immortelle extract |